Cardiovascular risk scores predict an individual’s risk of developing cardiovascular disease. Many were developed and validated in study cohorts on risk-factor lowering treatment – a cause of inaccuracy. In addition, risk scores are criticised as being biased towards the elderly due to the prominence of age as a risk predictor. Although present guidelines advocate the use of short-term (5-10 year) absolute risk scores, other approaches to redress this perceived imbalance such as lifetime risk scores are being considered. The overall objective of this thesis is to identify the most appropriate cardiovascular risk score for use in general practice, taking account of the impact of treatment and time on assessed risk. This objective was met b...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
OBJECTIVES: To assess whether delaying risk reduction treatment has a different impact on potential...
Cardiovascular risk scores predict an individual’s risk of developing cardiovascular disease. Many w...
Objectives : A young person with many risk factors may have the same level of risk as an older perso...
Background: National estimates of 'heart age' by government health organisations in the US, UK and C...
Objective: To compare the strengths and limitations of cardiovascular risk scores available for clin...
Background. Cardiovascular disease (CVD) prevention guidelines are generally based on the absolute r...
Aims: Estimation of cardiovascular disease risk, using SCORE (Systematic COronary Risk Evaluation) i...
Atherosclerotic cardiovascular diseases (CVDs) are the biggest causes of death worldwide. In most pe...
PubMed ID: 28976375Although the impact of cardiovascular (CV) risk factors decreases with aging, mod...
Background and aims: There are guideline discussions on a lifetime approach to cardiovascular risk. ...
Background and aims: There are guideline discussions on a lifetime approach to cardiovascular risk. ...
WOS: 000418482900007PubMed ID: 28976375Although the impact of cardiovascular (CV) risk factors decre...
OBJECTIVES: To assess whether delaying risk reduction treatment has a different impact on potential ...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
OBJECTIVES: To assess whether delaying risk reduction treatment has a different impact on potential...
Cardiovascular risk scores predict an individual’s risk of developing cardiovascular disease. Many w...
Objectives : A young person with many risk factors may have the same level of risk as an older perso...
Background: National estimates of 'heart age' by government health organisations in the US, UK and C...
Objective: To compare the strengths and limitations of cardiovascular risk scores available for clin...
Background. Cardiovascular disease (CVD) prevention guidelines are generally based on the absolute r...
Aims: Estimation of cardiovascular disease risk, using SCORE (Systematic COronary Risk Evaluation) i...
Atherosclerotic cardiovascular diseases (CVDs) are the biggest causes of death worldwide. In most pe...
PubMed ID: 28976375Although the impact of cardiovascular (CV) risk factors decreases with aging, mod...
Background and aims: There are guideline discussions on a lifetime approach to cardiovascular risk. ...
Background and aims: There are guideline discussions on a lifetime approach to cardiovascular risk. ...
WOS: 000418482900007PubMed ID: 28976375Although the impact of cardiovascular (CV) risk factors decre...
OBJECTIVES: To assess whether delaying risk reduction treatment has a different impact on potential ...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
Estimating absolute risk rather than measurement of blood pressure alone is considered the best way ...
OBJECTIVES: To assess whether delaying risk reduction treatment has a different impact on potential...